CSL LTDCSL LTDCSL LTD

CSL LTD

No trades
See on Supercharts
Market capitalization
‪79.12 B‬EUR
‪2.04 B‬EUR
‪11.96 B‬EUR
‪482.81 M‬
Beta (1Y)
0.40

About CSL LTD

CEO
Paul McKenzie
Website
Headquarters
Melbourne
Employees (FY)
‪32 K‬
Founded
1961
ISIN
AU000000CSL8
FIGI
BBG000BQ09Z1
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CSL LTD stocks are traded under the ticker CSJ.
CSL LTD is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for CSL LTD has a max estimate of 207.56 EUR and a min estimate of 140.46 EUR.
CSJ earnings for the last quarter are 1.50 EUR per share, whereas the estimation was 1.53 EUR resulting in a −2.14% surprise. The estimated earnings for the next quarter are 3.69 EUR per share. See more details about CSL LTD earnings.
CSL LTD revenue for the last quarter amounts to ‪5.62 B‬ EUR despite the estimated figure of ‪5.64 B‬ EUR. In the next quarter revenue is expected to reach ‪7.19 B‬ EUR.
Yes, you can track CSL LTD financials in yearly and quarterly reports right on TradingView.
CSJ net income for the last quarter is ‪1.80 B‬ EUR, while the quarter before that showed ‪545.74 M‬ EUR of net income which accounts for 229.29% change. Track more CSL LTD financial stats to get the full picture.
CSL LTD dividend yield was 1.31% in 2023, and payout ratio reached 52.45%. The year before the numbers were 1.18% and 47.96% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, CSJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CSL LTD stock right from TradingView charts — choose your broker and connect to your account.
CSJ reached its all-time high on Feb 19, 2020 with the price of 212.90 EUR, and its all-time low was 2.14 EUR and was reached on May 27, 2003.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has ‪32.00 K‬ employees. See our rating of the largest employees — is CSL LTD on this list?
We've gathered analysts' opinions on CSL LTD future price: according to them, CSJ price has a max estimate of 207.56 EUR and a min estimate of 140.46 EUR. Read a more detailed CSL LTD forecast: see what analysts think of CSL LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CSL LTD EBITDA is ‪4.01 B‬ EUR, and current EBITDA margin is 28.57%. See more stats in CSL LTD financial statements.